The obesity drug liraglutide cut migraine days in half in a small trial, though more research is needed to exclude the ...

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

A GLP-1 drug led to fewer days with headaches, a small pilot study of migraine sufferers shows. It may work by lowering pressure inside the head.

“Our findings show liraglutide may be effective for treating stubborn, high-frequency migraines in patients with obesity, and ...

Liraglutide, a member of the family of blockbuster weight-loss drugs, reduces headaches by half in a small study.

A common diabetes drug may be the next big thing for migraine relief. In a clinical study, obese patients with chronic ...

People with unresponsive chronic migraine and obesity experienced substantial relief after they started taking a GLP-1 drug, researchers in Italy have found.

Remote neuromodulation may offer safe, effective relief for a range of migraine types, including those with aura and chronic ...

A small, early-stage study published in the journal Headache suggested a diabetes drug may ease migraines by lowering ...

A new study finds that the diabetes drug liraglutide significantly reduced monthly migraine days in patients with obesity and ...

Chronic migraine sufferers who have not been able to find relief with available migraine drugs might now have hope in a new option. A new pilot study from Italian researcher Simone Braca and his ...

A GLP-1 medication used to treat type 2 diabetes and obesity may help cut a person's monthly migraine days by about half, a ...